Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product: Eliquis
Active Ingredient: Apixaban 2.5mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Pfizer New Zealand Limited
Manufacturer: Bristol-Myers Squibb Manufacturing Company, Humacao, Puerto Rico
Product: Eliquis
Active Ingredient: Apixaban 5mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Pfizer New Zealand Limited
Manufacturer: Bristol-Myers Squibb Manufacturing Company, Humacao, Puerto Rico
Product: Maxiclear Hayfever & Sinus Relief
Active Ingredients: Loratadine 2.5mg
Phenylephrine hydrochloride 10mg
Dosage Form: Tablet
New Zealand Sponsor: AFT Pharmaceuticals Limited
Manufacturer: Sigma Laboratories Limited, Goa, India
Dated this 20th day of June 2013.
DR DON MACKIE, Chief Medical Officer, Clinical Leadership, Protection and Regulation Business Unit, Ministry of Health (pursuant to delegation given by the Minister of Health on 6 July 2001).